MSB 6.36% $1.46 mesoblast limited

MSB to dispute FDA finding in Type A meeting, page-208

  1. 12,372 Posts.
    lightbulb Created with Sketch. 1106
    Hi ,
    Its disappointing but it should be pointed out we have.

    CHF , CLBP, ARDS, Crohns. All phase 3

    Most to be read out very soon.

    Cant say too many companies have that to look forward to.

    Aloha.


 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.